Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.
about
Permeability imaging in pediatric brain tumors.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat gliomaTumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in micePerfusion CT imaging of brain tumors: an overview.In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma modelBevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenograftsHigh-field small animal magnetic resonance oncology studies.A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).Gadolinium-based contrast agents for magnetic resonance cancer imaging.Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media.Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab.Visualizing vascular permeability and lymphatic drainage using labeled serum albuminPolydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model.Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.Pattern analysis accounts for heterogeneity observed in MRI studies of tumor angiogenesis.Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging.Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scannerCorrelative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer.Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function.
P2860
Q30392559-348B86B7-535E-4982-B519-007BB3B8628BQ30653828-F11AE290-90E8-487A-8A89-DC741506D3F1Q33464944-2C5A9AFE-7104-439C-9B4C-96595A535E7CQ33525581-C9EB2F26-3917-4323-99A8-0ECDBCA91A3BQ33584677-6E2EB013-F8FC-4826-B396-A5469E278118Q33738599-12238F1C-A1F7-42C1-9F7F-F5035E1DE46AQ33973363-55834791-D3B8-4BEF-9D15-AC98AE6CFEDEQ33989239-32AE2F9E-0E43-48A1-840C-DCEC4AE1B789Q34120237-9D24EB2E-2B9F-4857-BA0B-102E3CCFDFC3Q35018356-9E34253A-B1CE-4767-8474-01A26795ED5EQ35028461-0B18EBA3-39CB-45FE-A8D9-8E2D69272E19Q35312455-911DFF59-DD39-4E8E-B654-A2039A961DACQ35407573-F70CDD0F-19CD-4284-87D2-5E5EA8E0623EQ35622504-95BBAA71-F732-45DD-8CF0-7A0F8C01E2F9Q36555415-2EEF7CD6-B16C-4614-8F5F-94078022DB6CQ36803260-E5A223A2-A5F2-4256-A01A-6EBD87BFF934Q37102447-203145F0-5604-4AD4-9608-03B920878D7CQ37113814-D9290D17-84DD-461B-9002-662354205C7FQ37170947-E8CDC263-5B9B-405F-AFBC-E4BA617D2B6FQ37422783-33B334DE-1240-4F7C-8C1D-8CB601889CCDQ37450606-035A7105-D9B1-4F9C-9459-812FE70E0BA3Q37761659-FC638551-0E6E-434E-9AFB-36CF24BDC2A9Q37844434-410BAF1D-5F39-43AF-9BD0-09A8051B0D11Q38404839-8B692A23-355A-49AE-A12B-EAD5DA1EDA30Q39116695-04F87B87-9CE7-4E21-8296-46C9030DD3A0Q39218077-B9EC64D5-D2B3-4AFE-B067-6FC6C53BB0DBQ39502629-B13C1F30-DD2B-407E-A239-D8E6DDA2CA5EQ39763187-32C8DE39-3893-4BBD-9D4B-5E7FA6B0923CQ39837928-A3D3718C-2E5C-4F83-9043-EE5570AB5F40Q47920335-9073F8D5-367A-4A6D-9A04-9F0ED5CF4CDDQ51528303-FD4FE2E6-C9DE-4980-9770-F927BEC0ACA8
P2860
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Vascular permeability during a ...... bsequent tumor growth in rats.
@ast
Vascular permeability during a ...... bsequent tumor growth in rats.
@en
type
label
Vascular permeability during a ...... bsequent tumor growth in rats.
@ast
Vascular permeability during a ...... bsequent tumor growth in rats.
@en
prefLabel
Vascular permeability during a ...... bsequent tumor growth in rats.
@ast
Vascular permeability during a ...... bsequent tumor growth in rats.
@en
P2093
P2860
P1433
P1476
Vascular permeability during a ...... bsequent tumor growth in rats.
@en
P2093
Barbara Sennino
David M Shames
Donald M McDonald
Gerhard H Simon
Hans-Juergen Raatschen
Michael F Wendland
Robert C Brasch
P2860
P304
P356
10.1148/RADIOL.2472070363
P407
P577
2008-03-27T00:00:00Z